Skip to content
BALCAO · SERVICES-HEALTH SERVICES · SMALL CAP

Longduoduo Co. Ltd. LDDD

6 fiscal years on record · USD · FY2025 reported · SEC filings only
$1.8M
▼ 57.2% YoY
$-578,631
▼ 225.7% YoY
$-193,747
▼ 188.9% YoY

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

In brief

What this company does

LONGDUODUO OWNS THE SEVEN OPERATING COMPANIES THROUGH AN INTERMEDIARY HOLDING COMPANY REGISTERED IN HONG KONG. Our operating subsidiaries, Julong, Longduoduo Health Technology, Qingguo, Rongbin, Chengheng, Tianju and Yihua, serve, for some customers, as sales agents for third-party healthcare service providers and, for other customers, as distributors of services provided by third-party healthcare service providers. The Company mainly focuses on prevention of myocardial infarction, cerebral infarction, hemiplegia, and cardiovascular and cerebrovascular diseases. Since June of 2023, our operating subsidiaries have been primarily engaged in selling health maintenance services provided by Inner Mongolia Honghai Health Management Co., Ltd. (“Honghai”).

Written from the business description in Longduoduo Company Limited's annual report to the U.S. Securities and Exchange Commission, filed 26 September 2025. Every sentence was checked against that document before publication.

Growth

USD 1.8M
Revenue, FY2025 · full 6-year series below
Revenue $M Net income $M
FY2025 · Revenue 1.8 · Net income -0.6
3M6M-3M-6M
202020232025
Compound annual growth
−21.9%
+34.5%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +34.5% a year over the five years to FY2025.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

−35 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating -34.7% · Net -35.2%
10%20%-50%
202020222025
ROE
FY2025 · ROE -61.3%
20%40%-20%-40%-60%
202020222025
Three returns, three denominators.
Gross margin99.1%
Operating margin-34.7%
Net margin-35.2%
EBITDAUSD -522,517.00

Each USD of equity lost 61 cents this year.

Cash & shareholders

·
returned in FY2025 · dividends + net buybacks
Free cash flow $
FY2025 · FCF -193747.0
300000600000-100000-200000
202020222025

Total assetsUSD 2.1M
EquityUSD 703,691.00
CashUSD 1.6M
Current ratio1.39×

Equity funds 34% of total assets.

The 6-year record

6 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative—not applicable◌not available in our data
LDDD, 6-year financial record
Metric 202520242023202220212020
Revenue $B0.00.00.00.00.00.0
Operating income $B−0.00.00.00.0−0.0−0.0
EBITDA $B−0.00.00.00.0−0.0−0.0
Income tax $B0.00.00.00.00.0◌
Net income $B−0.00.00.0−0.0−0.0−0.0
Free cash flow $B−0.00.00.00.0−0.00.0
EPS, diluted $−0.020.010.04−0.00−0.29−0.00
Dividend / sh $◌◌◌◌◌◌
Payout % — not applicable: no dividend——————
ROE %−61.348.8————
Shares out B0.030.030.030.030.300.16

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 0 failures in 30 reconciliationsAUDITED

Reconciled in 6 of the 6 fiscal years we could check. 26 checks were skipped: the balance sheet is not tagged before 2020. 13 checks were skipped: EPS is not tagged before 2020. 13 checks were skipped: revenue is not tagged before 2020.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivityServices-Health Services
Listed onOTC market
Incorporated inNevada
Fiscal year endsJune 30
SEC categoryemerging growth company, smaller reporting company
Data on record since2020

Share this section

Download image